Brief: Amp Biosimilars announces Klaus K. Wilgenbus as new CEO
June 28 (Reuters) - Amp Biosimilars AG 1YA.MU :
* Announces Klaus K. Wilgenbus as new CEO
* Founding CEO Marc W. Hentz steps down in a planned
succession move
* Klaus K. Wilgenbus will lead firm as new CEO from July 1,
2016
Source text for Eikon: ID:nEQ1m1PTFa
Further company coverage: 1YA.MU
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 722 0920;))
Recent news on Northern Data AG
See all newsRCS - Cryptology Asset Grp - Cryptology Invests in New Crypto Launchpad VLaunch
Brief: Biosilu Healthcare: Main Shareholder Signals Exercise Of His Subscription Right
Brief: Biosilu Healthcare Ag Resolves On Capital Increase With Private Placement
Brief: Biosilu Healthcare to propose cash capital increase of c. EUR 5.0 mln
Brief: Biosilu Healthcare says CEO Klaus K. Wilgenbus resigns